Description: LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.
Home Page: www.lexagene.com
LXG Technical Analysis
500 Cummings Center
Beverly,
MA
01915
United States
Phone:
800 215 1824
Officers
| Name | Title |
|---|---|
| Dr. John F. Regan | Founder, Chairman & CEO |
| Mr. Jeffrey Mitchell | CFO, Treasurer & Corp. Sec. |
| Mr. Steven Armstrong | Chief Operating Officer |
| Mr. Allan John Fabbro | VP of Corp. Devel. |
| Nicole Ridgedale | Director of Corp. Marketing |
| Mr. Jay Adelaar | VP of Capital Markets |
Exchange: V
Country: CA : Canada
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 6.7788 |
| Price-to-Sales TTM: | 175.0937 |
| IPO Date: | |
| Fiscal Year End: | February |
| Full Time Employees: | 33 |